Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
19.78
-0.24 (-1.20%)
At close: Apr 1, 2025, 4:00 PM
20.02
+0.24 (1.22%)
After-hours: Apr 1, 2025, 4:54 PM EDT

Castle Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
5647465816201,1031,622
Upgrade
Market Cap Growth
28.53%28.53%-6.38%-43.76%-32.00%176.41%
Upgrade
Enterprise Value
2934933663687401,461
Upgrade
Last Close Price
20.0226.6521.5823.5442.8767.15
Upgrade
PE Ratio
32.2940.91----
Upgrade
PS Ratio
1.672.252.644.5311.7225.89
Upgrade
PB Ratio
1.251.641.481.552.683.90
Upgrade
P/TBV Ratio
2.132.132.122.273.423.90
Upgrade
P/FCF Ratio
15.3220.43---317.18
Upgrade
P/OCF Ratio
8.6311.51---164.43
Upgrade
EV/Sales Ratio
0.881.491.662.697.8623.33
Upgrade
EV/EBITDA Ratio
11.8820.00----
Upgrade
EV/EBIT Ratio
33.8056.90----
Upgrade
EV/FCF Ratio
8.0213.50---285.78
Upgrade
Debt / Equity Ratio
0.060.060.040.030.02-
Upgrade
Debt / EBITDA Ratio
0.960.96----
Upgrade
Debt / FCF Ratio
0.720.72----
Upgrade
Asset Turnover
0.680.680.490.300.210.22
Upgrade
Inventory Turnover
7.497.497.5510.677.475.61
Upgrade
Quick Ratio
6.976.975.907.8113.9420.24
Upgrade
Current Ratio
7.297.296.208.0914.2220.58
Upgrade
Return on Equity (ROE)
4.31%4.31%-14.54%-16.56%-7.56%-4.11%
Upgrade
Return on Assets (ROA)
1.10%1.10%-9.43%-12.52%-5.56%-1.88%
Upgrade
Return on Capital (ROIC)
1.22%1.22%-10.37%-13.68%-6.00%-2.00%
Upgrade
Return on Capital Employed (ROCE)
1.80%1.80%----
Upgrade
Earnings Yield
3.26%2.44%-9.89%-10.82%-2.84%-0.63%
Upgrade
FCF Yield
6.53%4.90%-3.31%-7.62%-2.04%0.32%
Upgrade
Buyback Yield / Dilution
-9.15%-9.15%-2.87%-3.65%-32.80%-118.63%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q